Healthcare in Autoimmune Eye Conditions MHRA approves teprotumumab as the first UK treatment for adults with moderate to severe Thyroid Eye Disease (TED) admin October 2, 2025 0 The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 7 May 2025, approved...Read More
